Antibiotic resistance represents a major public health challenge, and is associated with a high mortality rate. While bacteriophages—viruses that kill bacteria—could be a solution for fighting antibiotic-resistant pathogens, various obstacles stand in the way of their clinical development. To overcome them, researchers from Inserm, Université Sorbonne Paris Nord and Université Paris-Cité at the IAME Laboratory, in close collaboration with their counterparts at Institut Pasteur and the Paris Public Hospitals Group (AP-HP), have developed a model to better predict the efficacy of phage therapy and possibly develop more robust clinical trials. Their findings have been published in Cell Reports.
Click here for original story, Phage therapy: A model to predict its efficacy against pathogenic bacteria
Source: Phys.org